Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

JMACW

Maxpro Capital Acquisition (JMACW)

Maxpro Capital Acquisition Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:JMACW
FechaHoraFuenteTítuloSímboloCompañía
13/01/202315:13GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACWMaxpro Capital Acquisition Corporation
10/01/202315:05GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACWMaxpro Capital Acquisition Corporation
15/11/202207:00GlobeNewswire Inc.Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor AberrationsNASDAQ:JMACWMaxpro Capital Acquisition Corporation
14/09/202207:30GlobeNewswire Inc.Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.NASDAQ:JMACWMaxpro Capital Acquisition Corporation
26/11/202108:00GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and WarrantsNASDAQ:JMACWMaxpro Capital Acquisition Corporation
13/10/202117:03GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment OptionNASDAQ:JMACWMaxpro Capital Acquisition Corporation
07/10/202117:41GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public OfferingNASDAQ:JMACWMaxpro Capital Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:JMACW